1. Home
  2. VREX vs AVXL Comparison

VREX vs AVXL Comparison

Compare VREX & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$13.93

Market Cap

483.7M

Sector

Technology

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$5.07

Market Cap

397.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
AVXL
Founded
2016
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.7M
397.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VREX
AVXL
Price
$13.93
$5.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$16.67
$22.00
AVG Volume (30 Days)
300.0K
2.0M
Earning Date
02-05-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$844,600,000.00
N/A
Revenue This Year
$4.79
N/A
Revenue Next Year
$4.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.14
N/A
52 Week Low
$6.76
$2.86
52 Week High
$15.46
$13.99

Technical Indicators

Market Signals
Indicator
VREX
AVXL
Relative Strength Index (RSI) 75.49 67.85
Support Level $13.02 $4.67
Resistance Level $13.99 $4.44
Average True Range (ATR) 0.51 0.29
MACD 0.15 0.18
Stochastic Oscillator 95.22 89.40

Price Performance

Historical Comparison
VREX
AVXL

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: